Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2011 1
2012 1
2014 5
2015 2
2016 1
2018 1
2019 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators. Rouvière O, et al. Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21. Lancet Oncol. 2019. PMID: 30470502
Intérêt de la technique isotopique du ganglion sentinelle associée aux outils préopératoires de prédiction du risque d'envahissement ganglionnaire dans le cancer de la prostate : à propos de 200 patients.
Rousseau T, Lacoste J, Potiron E, Le Coguic G, Nevoux P, Aillet G, Campion L, Rousseau C. Rousseau T, et al. Among authors: potiron e. Prog Urol. 2014 Nov;24(13):785-6. doi: 10.1016/j.purol.2014.08.010. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461536 French. No abstract available.
Intérêt d'une deuxième série de biopsies prostatiques guidée par IRM avec cartographie 3D pour la re-classification des patients éligibles à une surveillance active du cancer de la prostate sur une première série de biopsies systématisées. Étude prospective.
Potiron E, Nevoux P, Rousseau T, Le Coguic G, Aillet G, Lacoste J. Potiron E, et al. Prog Urol. 2014 Nov;24(13):869-70. doi: 10.1016/j.purol.2014.08.189. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461715 French. No abstract available.
A new tumorgraft panel to accelerate precision medicine in prostate cancer.
Béraud C, Bidan N, Lassalle M, Lang H, Lindner V, Krucker C, Masliah-Planchon J, Potiron E, Lluel P, Massfelder T, Allory Y, Misseri Y. Béraud C, et al. Among authors: potiron e. Front Oncol. 2023 May 26;13:1130048. doi: 10.3389/fonc.2023.1130048. eCollection 2023. Front Oncol. 2023. PMID: 37305585 Free PMC article.
Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.
Pierrard V, Lebdai S, Kleinclauss F, Azzouzi AR, Terrier JE, Fortier E, Joniau S, Van Der Poel H, Salomon G, Casanova J, Medina-Lopez RA, Potiron E, Rigaud J, Vincendeau S, Rassweiler J, Villers A, Gaston R, Saussine C, Giai J, Gaillac B, Emberton M, Ruffion A. Pierrard V, et al. Among authors: potiron e. J Urol. 2019 Feb;201(2):315-321. doi: 10.1016/j.juro.2018.08.084. J Urol. 2019. PMID: 30248343 Free article.
17 results